Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07411443

AI-Enhanced Imaging in Population Breast Cancer Screening

Population-based Breast Cancer Screening Study Using AI-Assisted Imaging Technology

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
16,000 (estimated)
Sponsor
Fudan University · Academic / Other
Sex
Female
Age
35 Years – 69 Years
Healthy volunteers
Accepted

Summary

Artificial Intelligence (AI)-assisted imaging technologies (including AI-assisted breast ultrasound and AI-assisted mammography) can effectively improve the accuracy and efficiency of breast imaging examinations, but their application in large-scale population-based breast cancer screening remains very limited. This project aims to improve the effectiveness and feasibility of breast cancer screening by addressing the core issues and bottlenecks in population-based breast cancer screening. We will conduct a prospective cluster-controlled screening trial in the general population, with district-based cluster grouping. The intervention group will undergo combined screening using AI-assisted ultrasound plus AI-assisted mammography, while the control group will receive conventional screening: breast ultrasound for initial screening and mammography for secondary screening. Based on population screening practices, we will evaluate the effectiveness of AI-assisted imaging diagnostic technology in various technical aspects of actual screening and perform cost-effectiveness analyses. This study will investigate the application of AI-assisted breast imaging technology in population-based breast cancer screening, providing scientific evidence for the large-scale implementation of AI-assisted imaging technologies. Furthermore, by combining population screening practices with model simulations, we will explore multi-dimensional breast cancer screening strategies to optimize screening approaches and technologies for the Chinese population.

Conditions

Interventions

TypeNameDescription
DEVICEAI-assisted screeningThe intervention group will undergo combined screening using AI-assisted ultrasound plus AI-assisted mammography

Timeline

Start date
2025-01-01
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2026-02-13
Last updated
2026-02-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07411443. Inclusion in this directory is not an endorsement.